Reuters logo
BRIEF-Amicus Therapeutics Q3 loss per share $0.33
November 7, 2016 / 1:48 PM / a year ago

BRIEF-Amicus Therapeutics Q3 loss per share $0.33

Nov 7 (Reuters) - Amicus Therapeutics Inc

* Amicus Therapeutics announces third quarter 2016 financial results and corporate updates

* Q3 loss per share $0.33

* Q3 earnings per share view $-0.32 -- Thomson Reuters I/B/E/S

* Expects to remain within original 2016 net cash spend guidance of between $135 million and $155 million

* Qtrly total product revenue in q3 of 2016 was approximately $2.1 million Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below